Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 08, 2025 11:41 ET | Source: BioNTX

BIO CEO John Crowley to Receive Prestigious Dennis K. Stone Award at BioNTX iC³® Summit

DALLAS, Sept. 08, 2025 (GLOBE NEWSWIRE) -- BioNTX proudly announces that John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), has been named the 2025 recipient of the...
September 05, 2025 17:37 ET | Source: 22nd Century Group, Inc.

22nd Century to Participate in the HC Wainwright Conference in New York City September 9, 2025

MOCKSVILLE, N.C., Sept. 05, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the...
September 04, 2025 15:21 ET | Source: BioNTX

What’s Really Going On With Federal Funding? SMI and Travis Taylor Lead iC³® Summit Panel Discussion to Deliver Clarity in a Volatile Policy Era

DALLAS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Institutions, and organizations across the life sciences continuum are seeking clarity on how federal research and development (R&D) funding and...
September 04, 2025 09:30 ET | Source: High Roller Technologies, Inc.

High Roller Launches New Online Casino Brand in Finland

New localized casino brand Kassuuu embraces Finnish-slang, culture, and player-first entertainment Las Vegas, Nevada, Sept. 04, 2025 (GLOBE NEWSWIRE) -- High Roller Technologies (“High Roller” and...
September 03, 2025 10:30 ET | Source: BioNTX

2025 Rising Stars to Take the Stage at BioNTX iC³® Life Science & Healthcare Innovation Summit

DALLAS, Sept. 03, 2025 (GLOBE NEWSWIRE) -- BioNTX has announced the 2025 Rising Stars, a select group of companies recognized for their bold contributions to life sciences and healthcare...
August 28, 2025 08:00 ET | Source: Kyverna Therapeutics, Inc.

Kyverna Therapeutics Highlights Neuroimmunology CAR T Franchise and Registrational Phase 3 Trial Design in Myasthenia Gravis at Virtual KOL Event

KYV-101 has the potential to deliver durable, drug-free, disease-free remission in myasthenia gravis and set a new treatment standard for stiff person syndrome Innovative FDA-aligned KYSA-6 Phase 3...
August 27, 2025 10:00 ET | Source: BioNTX

BioNTX Announces BIO CEO John Crowley as Featured Speaker at iC³® Life Science & Healthcare Innovation Summit

DALLAS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- BioNTX, the leading biotechnology and healthcare innovation trade organization in North Texas, is thrilled to announce that John F. Crowley, President &...
August 26, 2025 22:29 ET | Source: Immuron Limited

Immuron partners with InvestorHub

MELBOURNE, Australia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) advises it has entered into a partnership with InvestorHub, a direct-to-investor engagement software...
August 18, 2025 13:15 ET | Source: BioNTX

BioNTX Announces 2025 Tech Transfer Showcase Finalists Pitch Competition at the 2025 iC³® Life Science & Healthcare Innovation Summit

DALLAS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- BioNTX is pleased to announce the finalists for the Annual Southwest Tech Transfer Showcase, set for Wednesday, September 17th, at the 2025 iC³® Life...
August 18, 2025 08:36 ET | Source: 22nd Century Group, Inc.

22nd Century to Participate in the Emerging Growth Conference on August 20, 2025

MOCKSVILLE, N.C., Aug. 18, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the...